Jefferies Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-269,542
Closed -$47.7M 2269
2020
Q1
$47.7M Sell
269,542
-88,438
-25% -$16.7M 0.53% 15
2019
Q4
$68.4M Buy
357,980
+76,884
+27% +$13.9M 0.53% 26
2019
Q3
$47.3M Buy
281,096
+59,652
+27% +$9.72M 0.37% 31
2019
Q2
$37.1M Buy
221,444
+205,372
+1,278% +$28.4M 0.27% 46
2019
Q1
$2.35M Sell
16,072
-44,939
-74% -$6.52M 0.02% 833
2018
Q4
$8.15M Buy
61,011
+25,433
+71% +$4.17M 0.07% 239
2018
Q3
$6.78M Sell
35,578
-21,982
-38% -$4.04M 0.04% 418
2018
Q2
$9.6M Buy
57,560
+22,805
+66% +$3.66M 0.05% 280
2018
Q1
$5.85M Sell
34,755
-114,631
-77% -$19.2M 0.03% 411
2017
Q4
$24.4M Buy
149,386
+55,045
+58% +$9.88M 0.11% 102
2017
Q3
$19.3M Buy
94,341
+24,626
+35% +$5.73M 0.13% 131
2017
Q2
$16.9M Buy
69,715
+38,748
+125% +$9.11M 0.11% 157
2017
Q1
$7.4M Buy
30,967
+30,341
+4,847% +$7.07M 0.06% 358
2016
Q4
$131K Sell
626
-137,931
-100% -$28.6M ﹤0.01% 1982
2016
Q3
$31.9M Sell
138,557
-212,350
-61% -$51.9M 0.16% 96
2016
Q2
$81.1M Buy
350,907
+280,601
+399% +$64.7M 0.37% 29
2016
Q1
$18.8M Sell
70,306
-10,830
-13% -$3.1M 0.11% 130
2015
Q4
$25.4M Buy
81,136
+8,581
+12% +$2.55M 0.14% 121
2015
Q3
$19.7M Buy
72,555
+30,518
+73% +$9.37M 0.11% 141
2015
Q2
$12.8M Sell
42,037
-214,901
-84% -$64.1M 0.07% 243
2015
Q1
$76.5M Buy
256,938
+247,826
+2,720% +$70.7M 0.43% 30
2014
Q4
$2.35M Buy
9,112
+9,012
+9,012% +$2.25M 0.01% 660
2014
Q3
$24K Sell
100
-100,934
-100% -$22.6M ﹤0.01% 2024
2014
Q2
$22.5M Buy
+101,034
New +$20.9M 0.19% 94

Other funds holding AGN

Jefferies Group's AGN Position: Q2 2020 in Review

Jefferies Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 269,542 shares — an estimated $47.7M sold.

Jefferies Group first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $81.1M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jefferies Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 269,542 Allergan plc shares in Q2 2020, an estimated $47.7M.
  • Jefferies Group first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Jefferies Group's Allergan plc position peaked at $81.1M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.